Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1

World Journal of Surgery

Volumn 34, Issue 6, 2010, Pages 1325-1331

  Salmeron, Maria D Balsalobre ^a   Gonzalez, Jose Manuel Rodriguez ^a   Fornos, Joan Sancho ^b   Goday, Albert ^b   Perez, Nuria Maria Torregrosa ^a   Zambudio, Antonio Rios ^a   Paricio, Pascual Parrilla ^a   Serra, Antonio Sitges ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Endocrine Unit   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROIDECTOMY; PROGNOSIS; RECURRENT DISEASE; REOPERATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CALCIUM; DIAGNOSTIC IMAGING; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID HORMONE; PARATHYROIDECTOMY; PROGNOSIS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955561074     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0605-2     Document Type: Article

References (32)

1. Cougard P, Calender A, Proye C et al. (1995) L'hyperparathyroïdie, signal privilegie du depistage des neoplasies endocriniennes multiples de type 1 (NEM1). Rev Fr Endocrinol Clin 36:360
2. Skarulis MC (1998) Clinical expressions of multiple endocrine neoplasia type 1 at the National Institutes of Health. Ann Intern Med 129:484-494
3. Brandi ML, Gagel RF, Angeli A et al. (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671
4. Rizzoli R, Green J, Marx SJ (1985) Primary hyperparathyroidism in familial multiple endocrine neoplasia type I: long-term followup of serum calcium levels after parathyroidectomy. Am J Med 78:467-474
5. Wells SA, Farndon JR, Dale JK et al. (1980) Long term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192:451
6. Hubbard JG, Sebag F, Maweja S et al. (2006) Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 141: 235-239
7. Kivlen MH, Bartlett DL, Libutti SK et al. (2001) Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 130:991-998
8. Skogseid BS, Eriksson B, Lundqvist G et al. (1991) Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 73:281-287
9. Kopp I, Bartsch D, Wild A et al. (2001) Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families. World J Surg 25:610-616
10. Burgess JR, David R, Greenaway TM et al. (1999) Osteoporosis in multiple endocrine neoplasia type 1. Arch Surg 134:1119-1123
11. Lambert LA, Shapiro SE, Lee JE et al. (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140:374-385
12. Kouvaraki MA, Lee JE, Shapiro SE et al. (2002) Genotypephenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 137:641-647
13. Bartsch D, Kopp I, Bergenfelz A et al. (1998) MEN1 gene mutations in 12 MEN 1 families and their associated tumors. Eur J Endocrinol 139:416
14. Doherty GM, Lairmore T, Moley JF et al. (2004) MEN-1 parathyroid adenoma development over time. World J Surg 28:1139-1142
15. Marx SJ, Menczel J, Campbell G et al. (1991) Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1. Clin Endocrinol (Oxf) 35:521-526
16. O'Riordain DS, O'Brien T, Grant CS et al. (1993) Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 and 2. Surgery 114:1031-1039
17. Hellman P, Skogseid B, Oberg K et al. (1998) Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 124:993-999
18. Casanova D, Sarfati E, DeFrancisco A et al. (1991) Secondary hyperparathyroidism: diagnosis of site of recurrence. World J Surg 15:546-549
19. Goudet P, Cougard P, Vergès B et al. (2001) Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe d'Etude des Néoplasies Endocriniennes Multiples Study Group. World J Surg 25:886-890
20. Thompson NW (1995) The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 238:269-280
21. Burgess JR, David R, Parameswaran V et al. (1998) The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 1133:126-129
22. Tonelli F, Spini S, Tommasi M et al. (2000) Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism. World J Surg 24:556-562
23. Proye CAG, Coropoulos A, Franz C et al. (1991) Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multiple gland disease. Surgery 110:1035-1042
24. Miura D, Wada N, Arici C et al. (2002) Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy? World J Surg 26:926-930
25. Weber CJ, Ritchie JC (1999) Retrospective analysis of sequential changes in serum intact parathyroid hormone levels during conventional parathyroid exploration. Surgery 126:1139-1143
26. Dackiw APB, Sussman JJ, Fritsche HA et al. (2000) Relative contributions of technetium Tc 99 m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135:550-555
27. Dotzenrath C, Cupisti K, Goretzki PE et al. (2001) Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia type I and IIa: is a more or less extended operation essential? Eur J Surg 167:173-178
28. Burgess JR, David R, Parameswaran V et al. (1998) The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 133:126-129
29. Shepperd JJ, Burgess JR, Greenaway TM et al. (2000) Preoperative sestamibi scanning and surgical finding at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1. Arch Surg 135:844-848
30. Shoback DM, Bilezikian JP, Turner SA et al. (2003) The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 88:5644-5649
31. Kraimps JL, Duh QY, Demeure M et al. (1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 112: 1080-1088
32. Lee CH, Tseng LM, Chen JY et al. (2006) Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol 13:103-109